Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-02-28
2006-02-28
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S042000, C514S043000, C514S04400A, C514S045000, C514S047000, C514S262100, C514S263100, C514S263200, C514S263230, C514S256000, C514S257000, C514S258100, C544S262000, C544S264000, C544S277000, C536S027300, C536S027220, C536S025320, C536S022100, C536S028500
Reexamination Certificate
active
07005425
ABSTRACT:
Methods are provided for treating arrhythmia in a manner that minimizes undesirable side effects, comprising administration of a therapeutically effective minimal dose of an A1adenosine receptor agonist with a therapeutically effective minimal dose of a beta blocker, calcium channel blocker, or a cardiac glycoside.
REFERENCES:
patent: 5789416 (1998-08-01), Lum et al.
patent: 6518245 (2003-02-01), Anderson et al.
patent: 6537974 (2003-03-01), Wolff
patent: 2001/0008883 (2001-07-01), Bellardinelli et al.
patent: 2003/0050275 (2003-03-01), Elzein et al.
patent: WO 01/23399 (2001-04-01), None
Wu et al. “A partial agonist of the A1-adenosine receptor selectively slows AV conduction in guninea pig hearts.” Am. J. Phisol. Heart Circ. Phisol., 280(1), H334-343, Jan. 2001.
GMO Manual: Clinical Section: Cardiovascular Disorders, Dept. of Navy, Bureau of Medicine and Surgery (1999).
Lai et al, “Effects of verapamil, propranolol, and procainamide on adenosine-induced negative dromotropism in human beings,” American Heart Journal, vol. 132 (No. 4), p. 768-775, (Oct. 2, 1996).
Snowdy et al, “A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig,” British Journal of Pharmacology, p. 137-146, (Mar. 2, 1999).
Belardinelli Luiz
Dhalla Arvinder
Clarke Pauline Ann
CV Therapeutics Inc.
Hartrum J. Elin
Khare Devesh
Lewis Brian
LandOfFree
Method for treating arrhythmias does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating arrhythmias, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating arrhythmias will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3627352